Neostigmine methylsulfate
These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION. NEOSTIGMINE METHYLSULFATE Injection, for intravenous use Initial U.S. Approval: 1939
Approved
Approval ID
971713db-d5ac-44c1-ada5-a56a943d79bf
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 18, 2022
Manufacturers
FDA
BE Pharmaceuticals Inc.
DUNS: 081499296
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Neostigmine methylsulfate
PRODUCT DETAILS
NDC Product Code71839-106
Application NumberANDA212512
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateMarch 17, 2022
Generic NameNeostigmine methylsulfate
INGREDIENTS (6)
PHENOLInactive
Quantity: 4.5 mg in 1 mL
Code: 339NCG44TV
Classification: IACT
NEOSTIGMINE METHYLSULFATEActive
Quantity: 1 mg in 1 mL
Code: 98IMH7M386
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM ACETATEInactive
Quantity: 0.2 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
Neostigmine methylsulfate
PRODUCT DETAILS
NDC Product Code71839-105
Application NumberANDA212512
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateMarch 17, 2022
Generic NameNeostigmine methylsulfate
INGREDIENTS (6)
NEOSTIGMINE METHYLSULFATEActive
Quantity: 0.5 mg in 1 mL
Code: 98IMH7M386
Classification: ACTIB
SODIUM ACETATEInactive
Quantity: 0.2 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
PHENOLInactive
Quantity: 4.5 mg in 1 mL
Code: 339NCG44TV
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT